Cost Effectiveness of Guanfacine Extended-Release versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder: Application of a Matching-Adjusted Indirect Comparison

Author: Erder M. Haim  

Publisher: Adis International

ISSN: 1175-5652

Source: Applied Health Economics and Health Policy, Vol.10, Iss.6, 2012-11, pp. : 381-395

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content